| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF03033174 |
| P698 | PubMed publication ID | 14715448 |
| P50 | author | Paul R. Sanberg | Q20709959 |
| P2093 | author name string | Samuel Saporta | |
| Alison E Willing | |||
| Don F Cameron | |||
| Alba I Rodriguez | |||
| P2860 | cites work | A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 |
| ??? | Q28251640 | ||
| Neural stem cells: from cell biology to cell replacement. | Q33918859 | ||
| Sertoli cell-enriched fractions in successful islet cell transplantation | Q34338335 | ||
| Lazaroids improve the survival of grafted rat embryonic dopamine neurons | Q35981738 | ||
| Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover | Q36236704 | ||
| Testicular development involves the spatiotemporal control of PDGFs and PDGF receptors gene expression and action | Q36382794 | ||
| Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease | Q39116027 | ||
| Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats | Q39427473 | ||
| Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats | Q41033079 | ||
| Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. | Q41095794 | ||
| Vectorial production of interleukin 1 and interleukin 6 by rat Sertoli cells cultured in a dual culture compartment system | Q42440341 | ||
| Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat. | Q43642878 | ||
| Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease | Q45291692 | ||
| Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model | Q45295346 | ||
| Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. | Q45300235 | ||
| Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results | Q45300364 | ||
| Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies | Q45300432 | ||
| Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats | Q45307246 | ||
| TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice | Q45889635 | ||
| Systemic 3-nitropropionic acid: long-term effects on locomotor behavior | Q48121479 | ||
| Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum | Q48193581 | ||
| Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol | Q48201659 | ||
| Neurobehavioral assessment of transplanted porcine Sertoli cells into the intact rat striatum | Q48269394 | ||
| Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. | Q48365871 | ||
| 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. | Q48403701 | ||
| Severe central-nervous-system toxicity associated with cyclosporin | Q48534631 | ||
| Intracerebral Transplantation of Testis-Derived Sertoli Cells Promotes Functional Recovery in Female Rats with 6-Hydroxydopamine-Induced Hemiparkinsonism | Q48586493 | ||
| Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression | Q48648462 | ||
| Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions | Q52293264 | ||
| Suppressive effects of insulin and insulin-like growth factor-1 (IGF1) on immune responses | Q68873191 | ||
| Central nervous system toxicity of cyclosporine in a rat model | Q69671798 | ||
| Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing | Q71327298 | ||
| Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid | Q72098398 | ||
| The testis-derived cultured Sertoli cell as a natural Fas-L secreting cell for immunosuppressive cellular therapy | Q73322009 | ||
| Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts | Q84063003 | ||
| P433 | issue | 6 | |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 443-450 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Neurotoxicity Research | Q15764278 |
| P1476 | title | Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study | |
| P478 | volume | 5 |
| Q34358408 | Adult stem cell transplantation: is gender a factor in stemness? |
| Q22305670 | Cell therapy in Huntington disease |
| Q58691859 | Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease |
| Q34329542 | Combined Strategy of Endothelial Cells Coating, Sertoli Cells Coculture and Infusion Improves Vascularization and Rejection Protection of Islet Graft |
| Q53164872 | Decreasing Loss of Cryopreserved-Thawed Rat Islets by Coculture with Sertoli Cells |
| Q92621566 | Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? |
| Q54384891 | Improved Survival and Function of Rat Cryopreserved Islets by Coculture With Sertoli Cells |
| Q48093429 | In vitro exposure of cultured porcine choroid plexus epithelial cells to immunosuppressant, anti-inflammatory, and psychoactive drugs |
| Q36465183 | Lentiviral transduction of rat Sertoli cells as a means to modify gene expression. |
| Q36225073 | New therapeutic approaches to Parkinson's disease including neural transplants. |
| Q35625437 | Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review. |
| Q88431956 | Sertoli Cells Avert Neuroinflammation-Induced Cell Death and Improve Motor Function and Striatal Atrophy in Rat Model of Huntington Disease |
| Q35757404 | Sertoli cell grafts for Huntington's disease. An opinion. |
| Q50734605 | Sertoli cells induce systemic donor-specific tolerance in xenogenic transplantation model |
| Q45295362 | Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease |
| Q26996178 | The Battle of the Sexes for Stroke Therapy: Female- Versus Male-Derived Stem Cells |
| Q52650342 | Therapeutic Potential of Pretreatment with Allograft Sertoli Cells Transplantation in Brain Ischemia by Improving Oxidative Defenses. |
| Q35790833 | Use of Sertoli cell transplants to provide local immunoprotection for tissue grafts |
Search more.